Fast selection of maribavir resistant cytomegalovirus in a bone marrow transplant recipient (Q34841085)

4 August 2017

0 references

Fast selection of maribavir resistant cytomegalovirus in a bone marrow transplant recipient (English)

1 reference

4 August 2017

0 references

5

Thomas Mertens

1 reference

4 August 2017

Axel Schubert

1

1 reference

4 August 2017

Karoline Ehlert

2

1 reference

4 August 2017

Susanne Schuler-Luettmann

3

1 reference

4 August 2017

Eva Gentner

4

1 reference

4 August 2017

Detlef Michel

6

1 reference

4 August 2017

19 July 2013

1 reference

4 August 2017

BMC Infectious Diseases

1 reference

4 August 2017

13

1 reference

4 August 2017

330

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2334-13-330

4 August 2017

0 references

cites work

The biology of cytomegalovirus drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3720178

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3720178

Antiviral drug resistance of human cytomegalovirus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3720178

Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3720178

Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3720178

The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3720178

Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3720178

Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3720178

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3720178

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2334-13-330

Virologic characterization of multidrug-resistant cytomegalovirus infection in 2 transplant recipients treated with maribavir

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2334-13-330

GCV resistance due to the mutation A594P in the cytomegalovirus protein UL97 is partially reconstituted by a second mutation at D605E.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2334-13-330

Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3720178

Cytomegalovirus UL97 kinase mutations that confer maribavir resistance

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23870704

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antiviral treatment of cytomegalovirus infection and resistant strains

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23870704

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2334-13-330

1 reference

4 August 2017

1 reference

4 August 2017

1 reference